# NIH National Cancer Institute: mouse bone marrow culture yields 1.5 billion cDC1 cells per mouse in 23 days

- Published: 2026-11-05 08:06 UTC
- Section: Life & Health › Biology & biochemistry
- Tags: cDC1 cells, iDC1 culture, mouse bone marrow culture, dendritic cell generation, CD103 cDC1, cross-presentation, FLT3L GM-CSF Kit ligand, tumor immunology, preclinical research, Myeloid Cells journal
- URL: https://realtech.media/news/rt-1b069fca47035237fa372807_nih_national_cancer/

**Researchers at the National Cancer Institute developed an iDC1 culture of mouse bone marrow cells with over 95% cDC1 purity. The yield is at least 75 times higher than earlier cytokine-based methods.**

![NIH National Cancer Institute: mouse bone marrow culture yields 1.5 billion cDC1 cells per mouse in 23 days](https://sgzwpqqelzmajkcubgkl.supabase.co/storage/v1/object/public/rt-media/2026/11/e6bbf6fb4c71dced.jpg)
*Lilly_M, Wikimedia Commons, CC BY-SA 3.0*

Researchers at the National Cancer Institute, National Institutes of Health, developed a bone marrow-derived culture system that produces large numbers of highly enriched CD103-positive cDC1 cells from mice. The work was published in Myeloid Cells and reported by EurekAlert on 3 November 2026. The system is called induced cDC1, or iDC1 [1].

Conventional type 1 dendritic cells (cDC1) help initiate responses against intracellular pathogens and tumors and can cross-present cell-associated antigens to CD8-positive T cells. They are rare in vivo, which makes it hard to obtain sufficient and uniform populations for mechanistic and preclinical studies [1].

## 23-day protocol and yield

The protocol uses the cytokines FLT3L, low-dose GM-CSF and Kit ligand over 23 days. According to the authors, one mouse's bone marrow gave an estimated 1.5 billion CD103-positive cDC1 cells. More than 95% of the final culture consisted of the target cells. The reported yield was at least 75 times higher than that of previously available recombinant cytokine-based approaches [1].

Compared with other bone marrow-derived dendritic cell methods, iDC1 cultures contained fewer cDC2 cells, plasmacytoid dendritic cells, macrophages and other non-target cells. Transcriptomic analyses and reference comparisons placed iDC1 cells closest to the cDC1 lineage and clearly distinct from macrophages [1].

## Function and mechanism

After innate immune stimulation, the cells increased expression of co-stimulatory molecules and secreted IL-12p40 and several chemokines. In functional experiments, iDC1 cells cross-presented cell-associated antigen to CD8-positive T cells. In a mouse transfer experiment, iDC1 cells supported restoration of this response in two of four cDC1-deficient recipients. The authors note that further research is needed to improve these in vivo responses [1].

Mechanistic experiments identified distinct roles for the culture factors. Kit ligand and GM-CSF acted together in the early phase of cDC1 generation, while in later stages GM-CSF supported proliferation and survival. The +32 kb Irf8 enhancer, STAT5 and BRD4-associated regulatory programs contribute to efficient iDC1 generation [1].

The authors describe iDC1 as a reproducible source of relatively uniform cDC1 cells for studies of antigen processing, dendritic cell biology, vaccine research and tumor immunology. The method was developed with mouse bone marrow cells. Whether comparable approaches can be established with human cells, and whether they can support translational or clinical applications, remains to be determined [1].

## Sources

1. [EurekAlert](https://www.eurekalert.org/news-releases/1150088)

---

Source: RealTech, realtech.media — https://realtech.media/news/rt-1b069fca47035237fa372807_nih_national_cancer/